2025 ICD-10-CM code Z79.83
This code signifies the ongoing, long-term use of bisphosphonate medications by a patient. It is used to document the reason for a healthcare encounter related to the management of this medication regimen.
Medical necessity for the continued use of bisphosphonates must be supported by documentation of the underlying condition being treated, such as osteoporosis, Paget's disease, or other conditions requiring bisphosphonate therapy. Ongoing monitoring and management of the therapy are also necessary to ensure efficacy and safety.
The clinician is responsible for evaluating the patient's response to bisphosphonate therapy, managing any side effects, and ensuring appropriate ongoing monitoring related to the medication use. This might include bone density scans, laboratory tests, and assessments for medication-related adverse events.
In simple words: This code indicates that the patient is currently taking bisphosphonates, a type of medication typically prescribed for bone conditions, as part of their ongoing, long-term treatment.
Long term (current) use of bisphosphonates. This code indicates the patient is currently taking bisphosphonates as a long-term medication. It is used for encounters where the reason for the visit is related to the management or monitoring of bisphosphonate therapy. It should be used alongside a procedure code if a procedure is performed during the encounter. It does not indicate the underlying condition being treated by the bisphosphonates.
Example 1: A patient with a history of osteoporosis has a routine follow-up appointment to discuss her ongoing bisphosphonate therapy. The physician assesses for side effects, reviews recent bone density scan results, and refills the medication. Z79.83 is used to indicate the reason for the encounter., A patient experiences jaw pain several months after starting bisphosphonate treatment. The physician evaluates for osteonecrosis of the jaw, a potential side effect of bisphosphonates. Z79.83 and a code for jaw pain are used to document the encounter., A patient with Paget's disease of bone is seen for ongoing management of his bisphosphonate therapy. The physician monitors the patient's response to treatment and evaluates for any complications. Z79.83 and a code for Paget's disease are used.
The medical record should document the specific bisphosphonate being used, the indication for the medication, the duration of therapy, the patient's response to treatment, monitoring results (e.g., bone density scans, lab tests), and any side effects or complications.
** This code is not to be used if the patient is starting bisphosphonate therapy. It is specifically for long-term (current) use.
- Specialties:Endocrinology, Rheumatology, Oncology, Orthopedics, Geriatrics
- Place of Service:Office, Outpatient Hospital, Telehealth Provided in Patient’s Home